|
業務類別
|
Biotechnology |
|
業務概覽
|
Invivyd Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of monoclonal antibody (mAb) therapies for the prevention and treatment of serious viral infectious diseases. Its lead product, PEMGARDA (pemivibart), received emergency use authorization from the U.S. FDA for the pre-exposure prevention of COVID-19 in certain immunocompromised individuals. The company is also developing next-generation antibody candidates, including VYD2311 for COVID-19 and VBY329 for RSV infections, while continuing research on additional antibodies targeting other viral diseases such as measles. |
| 公司地址
| 209 Church Street, New Haven, CT, USA, 06510 |
| 電話號碼
| +1 781 819-0080 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.invivyd.com |
| 員工數量
| 122 |
| Mr. William Duke, M.B.A. |
Principal Executive Officer, Chief Financial Officer and Principal Accounting Officer |
-- |
05/03/2026 |
| Mr. Robert Allen, PhD |
Chief Scientific Officer |
-- |
07/04/2025 |
| Ms. Julie Green, M.B.A. |
Chief Human Resources Officer and Head of Communications |
美元 398.90K |
07/04/2025 |
| Mr. Timothy Lee |
Chief Commercial Officer |
美元 240.42K |
07/04/2025 |
| Ms. Jill Andersen, J.D. |
Chief Legal Officer and Corporate Secretary |
-- |
07/04/2025 |
|
|
| Mr. Kevin F. Mclaughlin |
Independent Director |
05/03/2026 |
| Mr. Ajay Royan |
Director |
05/03/2026 |
| Mr. Marc Elia |
Chairman of the Board |
05/03/2026 |
| Dr. Paul B. Bolno, M.B.A.,M.D. |
Director |
05/03/2026 |
| Ms. Tamsin Berry |
Independent Director |
05/03/2026 |
| Mr. Terrance G. Mcguire |
Independent Director |
05/03/2026 |
|
|
|
|
